Firma Nanion Technologies, Autor bei PR-Web

The SyncroPatch 384 is installed at the FDA for cardiac safety pharmacology studies

Posted on 10. March 202211. March 2022 by Firma Nanion Technologies Posted in General Tagged automated patch clamp, cardiac safety, cardiac safety testing, electrophysiology, Food and Drug Administration, hERG, Ion Channels, patch clamp, Pharmacology, SyncroPatch 384

Nanion is pleased to announce that a SyncroPatch 384 instrument has been installed at the Food and Drug Administration (FDA) at their Silver Spring site in Maryland. The SyncroPatch 384 will be used for high throughput automated patch clamp experiments […]

Nanion Technologies Announces the Winners of the SURFE²R Grant Award – a Platform for Membrane Transporter Research and Screening

Posted on 31. October 2019 by Firma Nanion Technologies Posted in General Tagged antibiotic transport, assay, cell, grant application, membrane transporter, nanion, nanobodies, project, research, slc, ssm, wall

Transporter proteins are gaining increasing interest in academic science and as therapeutic targets. Nanion’s two platforms, SURFE²R N1 and SURFE²E 96SE facilitate functional assays of electrogenic transport to elucidate kinetics, pharmacology, and other parameters of membrane transport activity. Earlier this […]